Back to Peptide Encyclopedia
OtherPreclinical
SLU-PP-332
ERRα/γ agonist, next-generation 'exercise mimetic'.
Research Only3 protocols
Research-only — no FDA/EMA approval
·Educational information. Not medical advice or a recommendation for use.Key Facts: SLU-PP-332
Category
Other
Evidence
Preclinical
Availability
Research Only
Protocols
3
Research Overview & Mechanisms
Activates ERRα/γ receptors, mimicking metabolic benefits of exercise.
Reported Research Benefits
Exercise mimetic
Metabolism
Endurance
Available Protocols
Frequently Asked Questions
FAQ
ERRα/γ agonist, next-generation 'exercise mimetic'.
Advanced Compound Intelligence
—
Human studies
—
Key studies
—
Interactions
Preclinical
Evidence tier
Verified intelligence
Research summaryClinical Evidence
Preclinical
View all studies on PubMedPrimarily animal studies and in-vitro data. Human clinical trials are limited or absent.
Scientific Sources & Further Reading
Explore peer-reviewed research about SLU-PP-332:
External links open in new tabs. Always verify information with qualified healthcare providers.
Important Disclaimer
The content of this website is provided exclusively for informational and educational purposes within the context of research literature.
Read the full Disclaimer →